{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:37Z","timestamp":1792790557022,"version":"4.5.0"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004361","name":"Krebsliga Schweiz","doi-asserted-by":"publisher","award":["KFS-2648-08-2010"],"award-info":[{"award-number":["KFS-2648-08-2010"]}],"id":[{"id":"10.13039\/501100004361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Swiss National Science Foundation NCCR RNA and Disease","id":[{"id":"https:\/\/ror.org\/00yjd3n13","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lin28 RNA-binding proteins are stem-cell factors that play key roles in development. Lin28 suppresses the biogenesis of let-7 microRNAs and regulates mRNA translation. Notably, let-7 inhibits Lin28, establishing a double-negative feedback loop. The Lin28\/let-7 axis resides at the interface of metabolic reprogramming and oncogenesis and is therefore a potential target for several diseases. In this study, we use compound-C1632, a drug-like Lin28 inhibitor, and show that the Lin28\/let-7 axis regulates the balance between ketogenesis and lipogenesis in liver cells. Hence, Lin28 inhibition activates synthesis and secretion of ketone bodies whilst suppressing lipogenesis. This occurs at least partly via\u00a0let-7-mediated inhibition of nuclear receptor co-repressor 1, which releases ketogenesis gene expression mediated by peroxisome proliferator-activated receptor-alpha. In this way, small-molecule Lin28 inhibition protects against lipid accumulation in multiple cellular and male mouse models of hepatic steatosis. Overall, this study highlights Lin28 inhibitors as candidates for the treatment of hepatic disorders of abnormal lipid deposition.<\/jats:p>","DOI":"10.1038\/s41467-022-35481-1","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:02:57Z","timestamp":1672012977000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological inhibition of Lin28 promotes ketogenesis and restores lipid homeostasis in models of non-alcoholic fatty liver disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Evangelia","family":"Lekka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Kokanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Mosole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Civenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6538-3581","authenticated-orcid":false,"given":"Sandro","family":"Schmidli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Laski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1893-6504","authenticated-orcid":false,"given":"Alice","family":"Ghidini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavithra","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alok","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-557X","authenticated-orcid":false,"given":"Carlo V.","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4160-7135","authenticated-orcid":false,"given":"Jonathan","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"35481_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cell.2010.02.007","volume":"140","author":"SR Viswanathan","year":"2010","unstructured":"Viswanathan, S. R. & Daley, G. Q. Lin28: A microRNA regulator with a macro role. Cell 140, 445\u2013449 (2010).","journal-title":"Cell"},{"key":"35481_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.tcb.2012.06.001","volume":"22","author":"JE Thornton","year":"2012","unstructured":"Thornton, J. E. & Gregory, R. I. How does Lin28 let-7 control development and disease? Trends cell Biol. 22, 474\u2013482 (2012).","journal-title":"Trends cell Biol."},{"key":"35481_CR3","first-page":"4","volume":"4","author":"LH Nguyen","year":"2015","unstructured":"Nguyen, L. H. & Zhu, H. Lin28 and let-7 in cell metabolism and cancer. Transl. pediatrics 4, 4\u201311 (2015).","journal-title":"Transl. pediatrics"},{"key":"35481_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.tem.2015.12.006","volume":"27","author":"ET Jun-Hao","year":"2016","unstructured":"Jun-Hao, E. T., Gupta, R. R. & Shyh-Chang, N. Lin28 and let-7 in the Metabolic Physiology of Aging. Trends Endocrinol. Metab.: TEM 27, 132\u2013141 (2016).","journal-title":"Trends Endocrinol. Metab.: TEM"},{"key":"35481_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1567-133X(03)00140-6","volume":"3","author":"DH Yang","year":"2003","unstructured":"Yang, D. H. & Moss, E. G. Temporally regulated expression of Lin-28 in diverse tissues of the developing mouse. Gene Expr. patterns: GEP 3, 719\u2013726 (2003).","journal-title":"Gene Expr. patterns: GEP"},{"key":"35481_CR6","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.2337\/db16-1558","volume":"66","author":"JD Kim","year":"2017","unstructured":"Kim, J. D., Toda, C., Ramirez, C. M., Fernandez-Hernando, C. & Diano, S. Hypothalamic Ventromedial Lin28a Enhances Glucose Metabolism in Diet-Induced Obesity. Diabetes 66, 2102\u20132111 (2017).","journal-title":"Diabetes"},{"key":"35481_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molcel.2012.08.004","volume":"48","author":"ML Wilbert","year":"2012","unstructured":"Wilbert, M. L. et al. LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol. cell 48, 195\u2013206 (2012).","journal-title":"Mol. cell"},{"key":"35481_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1261\/rna.036491.112","volume":"19","author":"M Hafner","year":"2013","unstructured":"Hafner, M. et al. Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition. RNA (N. Y., N. Y.) 19, 613\u2013626 (2013).","journal-title":"RNA (N. Y., N. Y.)"},{"key":"35481_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1261\/rna.1155108","volume":"14","author":"MA Newman","year":"2008","unstructured":"Newman, M. A., Thomson, J. M. & Hammond, S. M. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA (N. Y., N. Y.) 14, 1539\u20131549 (2008).","journal-title":"RNA (N. Y., N. Y.)"},{"key":"35481_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/ncb1759","volume":"10","author":"A Rybak","year":"2008","unstructured":"Rybak, A. et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. cell Biol. 10, 987\u2013993 (2008).","journal-title":"Nat. cell Biol."},{"key":"35481_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1154040","volume":"320","author":"SR Viswanathan","year":"2008","unstructured":"Viswanathan, S. R., Daley, G. Q. & Gregory, R. I. Selective blockade of microRNA processing by Lin28. Sci. (N. Y., N. Y.) 320, 97\u2013100 (2008).","journal-title":"Sci. (N. Y., N. Y.)"},{"key":"35481_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cell.2009.08.002","volume":"138","author":"I Heo","year":"2009","unstructured":"Heo, I. et al. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138, 696\u2013708 (2009).","journal-title":"Cell"},{"key":"35481_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0012-1606(03)00126-X","volume":"258","author":"EG Moss","year":"2003","unstructured":"Moss, E. G. & Tang, L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Developmental Biol. 258, 432\u2013442 (2003).","journal-title":"Developmental Biol."},{"key":"35481_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/35002607","volume":"403","author":"BJ Reinhart","year":"2000","unstructured":"Reinhart, B. J. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901\u2013906 (2000).","journal-title":"Nature"},{"key":"35481_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","volume":"147","author":"H Zhu","year":"2011","unstructured":"Zhu, H. et al. The Lin28\/let-7 axis regulates glucose metabolism. Cell 147, 81\u201394 (2011).","journal-title":"Cell"},{"key":"35481_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ng.593","volume":"42","author":"H Zhu","year":"2010","unstructured":"Zhu, H. et al. Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies. Nat. Genet. 42, 626\u2013630 (2010).","journal-title":"Nat. Genet."},{"key":"35481_CR17","doi-asserted-by":"publisher","first-page":"21075","DOI":"10.1073\/pnas.1118922109","volume":"108","author":"RJ Frost","year":"2011","unstructured":"Frost, R. J. & Olson, E. N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl Acad. Sci. USA 108, 21075\u201321080 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35481_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cell.2013.09.059","volume":"155","author":"N Shyh-Chang","year":"2013","unstructured":"Shyh-Chang, N. et al. Lin28 enhances tissue repair by reprogramming cellular metabolism. Cell 155, 778\u2013792 (2013).","journal-title":"Cell"},{"key":"35481_CR19","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/jcmm.12369","volume":"19","author":"M Zhang","year":"2015","unstructured":"Zhang, M. et al. Lin28a protects against cardiac ischaemia\/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway. J. Cell. Mol. Med. 19, 1174\u20131182 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"35481_CR20","doi-asserted-by":"crossref","unstructured":"Herrlinger, S. et al. Lin28-mediated temporal promotion of protein synthesis is crucial for neural progenitor cell maintenance and brain development in mice. Development (Cambridge, England) 146, 173765 (2019).","DOI":"10.1242\/dev.173765"},{"key":"35481_CR21","doi-asserted-by":"publisher","first-page":"e09431","DOI":"10.7554\/eLife.09431","volume":"4","author":"L Wu","year":"2015","unstructured":"Wu, L. et al. Precise let-7 expression levels balance organ regeneration against tumor suppression. eLife 4, e09431 (2015).","journal-title":"eLife"},{"key":"35481_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep38805","volume":"6","author":"F Ma","year":"2016","unstructured":"Ma, F. et al. Lin28a promotes self-renewal and proliferation of dairy goat spermatogonial stem cells (SSCs) through regulation of mTOR and PI3K\/AKT. Sci. Rep. 6, 38805 (2016).","journal-title":"Sci. Rep."},{"key":"35481_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.cmet.2014.09.001","volume":"20","author":"AN Dubinsky","year":"2014","unstructured":"Dubinsky, A. N. et al. Let-7 coordinately suppresses components of the amino acid sensing pathway to repress mTORC1 and induce autophagy. Cell Metab. 20, 626\u2013638 (2014).","journal-title":"Cell Metab."},{"key":"35481_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/ng.392","volume":"41","author":"SR Viswanathan","year":"2009","unstructured":"Viswanathan, S. R. et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet 41, 843\u2013848 (2009).","journal-title":"Nat. Genet"},{"key":"35481_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay, N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat. Rev. Cancer 16, 635\u2013649 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"35481_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau, J., Menezes, M. R., Cao, S. & Hagan, J. P. The LIN28\/let-7 Pathway in Cancer. Front Genet 8, 31 (2017).","journal-title":"Front Genet"},{"key":"35481_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","volume":"18","author":"S Roush","year":"2008","unstructured":"Roush, S. & Slack, F. J. The let-7 family of microRNAs. Trends cell Biol. 18, 505\u2013516 (2008).","journal-title":"Trends cell Biol."},{"key":"35481_CR28","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.15252\/embj.201796438","volume":"36","author":"FR Dejure","year":"2017","unstructured":"Dejure, F. R. & Eilers, M. MYC and tumor metabolism: chicken and egg. EMBO J. 36, 3409\u20133420 (2017).","journal-title":"EMBO J."},{"key":"35481_CR29","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1101\/gad.228122.113","volume":"27","author":"E White","year":"2013","unstructured":"White, E. Exploiting the bad eating habits of Ras-driven cancers. Genes Dev. 27, 2065\u20132071 (2013).","journal-title":"Genes Dev."},{"key":"35481_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6212","volume":"5","author":"X Ma","year":"2014","unstructured":"Ma, X. et al. Lin28\/let-7 axis regulates aerobic glycolysis and cancer progression via PDK1. Nat. Commun. 5, 5212 (2014).","journal-title":"Nat. Commun."},{"key":"35481_CR31","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1038\/s41388-019-0735-4","volume":"38","author":"C Chen","year":"2019","unstructured":"Chen, C. et al. Targeting LIN28B reprograms tumor glucose metabolism and acidic microenvironment to suppress cancer stemness and metastasis. Oncogene 38, 4527\u20134539 (2019).","journal-title":"Oncogene"},{"key":"35481_CR32","doi-asserted-by":"publisher","first-page":"e48115","DOI":"10.15252\/embr.201948115","volume":"20","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP-1. EMBO Rep. 20, e48115 (2019).","journal-title":"EMBO Rep."},{"key":"35481_CR33","doi-asserted-by":"publisher","first-page":"21310","DOI":"10.1074\/jbc.C800108200","volume":"283","author":"E Piskounova","year":"2008","unstructured":"Piskounova, E. et al. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J. Biol. Chem. 283, 21310\u201321314 (2008).","journal-title":"J. Biol. Chem."},{"key":"35481_CR34","doi-asserted-by":"publisher","unstructured":"Wu, P. Inhibition of RNA-binding proteins with small molecules. Nature Reviews Chemistry 4, https:\/\/doi.org\/10.1038\/s41570-020-0201-4 (2020).","DOI":"10.1038\/s41570-020-0201-4"},{"key":"35481_CR35","doi-asserted-by":"publisher","unstructured":"Bush, J. A. et al. Systematically Studying the Effect of Small Molecules Interacting with RNA in Cellular and Preclinical Models. ACS Chem. Biol. https:\/\/doi.org\/10.1021\/acschembio.1c00014 (2021).","DOI":"10.1021\/acschembio.1c00014"},{"key":"35481_CR36","doi-asserted-by":"publisher","first-page":"10208","DOI":"10.1039\/C6OB01945E","volume":"14","author":"HL Lightfoot","year":"2016","unstructured":"Lightfoot, H. L., Miska, E. A. & Balasubramanian, S. Identification of small molecule inhibitors of the Lin28-mediated blockage of pre-let-7g processing. Org. Biomol. Chem. 14, 10208\u201310216 (2016).","journal-title":"Org. Biomol. Chem."},{"key":"35481_CR37","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1021\/acschembio.6b00232","volume":"11","author":"M Roos","year":"2016","unstructured":"Roos, M. et al. A Small-Molecule Inhibitor of Lin28. ACS Chem. Biol. 11, 2773\u20132781 (2016).","journal-title":"ACS Chem. Biol."},{"key":"35481_CR38","doi-asserted-by":"publisher","first-page":"13630","DOI":"10.1021\/jacs.6b06965","volume":"138","author":"D Lim","year":"2016","unstructured":"Lim, D., Byun, W. G., Koo, J. Y., Park, H. & Park, S. B. Discovery of a Small-Molecule Inhibitor of Protein-MicroRNA Interaction Using Binding Assay with a Site-Specifically Labeled Lin28. J. Am. Chem. Soc. 138, 13630\u201313638 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"35481_CR39","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1021\/acsmedchemlett.8b00323","volume":"9","author":"D Lim","year":"2018","unstructured":"Lim, D., Byun, W. G. & Park, S. B. Restoring Let-7 microRNA Biogenesis Using a Small-Molecule Inhibitor of the Protein-RNA Interaction. ACS medicinal Chem. Lett. 9, 1181\u20131185 (2018).","journal-title":"ACS medicinal Chem. Lett."},{"key":"35481_CR40","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1016\/j.celrep.2018.04.116","volume":"23","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28. Cell Rep. 23, 3091\u20133101 (2018).","journal-title":"Cell Rep."},{"key":"35481_CR41","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1021\/acsmedchemlett.8b00126","volume":"9","author":"DA Lorenz","year":"2018","unstructured":"Lorenz, D. A. et al. Expansion of cat-ELCCA for the Discovery of Small Molecule Inhibitors of the Pre-let-7-Lin28 RNA-Protein Interaction. ACS medicinal Chem. Lett. 9, 517\u2013521 (2018).","journal-title":"ACS medicinal Chem. Lett."},{"key":"35481_CR42","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/cbic.201900467","volume":"21","author":"WG Byun","year":"2020","unstructured":"Byun, W. G., Lim, D. & Park, S. B. Discovery of Small-Molecule Modulators of Protein-RNA Interactions by Fluorescence Intensity-Based Binding Assay. Chembiochem: a Eur. J. Chem. Biol. 21, 818\u2013824 (2020).","journal-title":"Chembiochem: a Eur. J. Chem. Biol."},{"key":"35481_CR43","unstructured":"Albright, J. D., Powell, D. W. & Dusza, J. P. Preparation of N-substituted N-[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, -carbamates and -ureas as anxiolytics and antiepileptics. US4654343A (1987)."},{"key":"35481_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nchembio.296","volume":"6","author":"SV Frye","year":"2010","unstructured":"Frye, S. V. The art of the chemical probe. Nat. Chem. Biol. 6, 159\u2013161 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"35481_CR45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/jm00137a020","volume":"24","author":"JD Albright","year":"1981","unstructured":"Albright, J. D. et al. Synthesis and anxiolytic activity of 6-(substituted-phenyl)\u22121,2,4-triazolo[4,3-b]pyridazines. J. medicinal Chem. 24, 592\u2013600 (1981).","journal-title":"J. medicinal Chem."},{"key":"35481_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/2326-6066.CIR-18-0331","volume":"7","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. LIN28\/let-7\/PD-L1 Pathway as a Target for Cancer Immunotherapy. Cancer Immunol. Res. 7, 487\u2013497 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"35481_CR47","doi-asserted-by":"publisher","unstructured":"Chen, H., Sa, G., Lin, L., He, S. & Wu, T. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma. European journal of pharmacology, 173757, https:\/\/doi.org\/10.1016\/j.ejphar.2020.173757 (2020).","DOI":"10.1016\/j.ejphar.2020.173757"},{"key":"35481_CR48","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/stem.1423","volume":"31","author":"G Shinoda","year":"2013","unstructured":"Shinoda, G. et al. Fetal deficiency of lin28 programs life-long aberrations in growth and glucose metabolism. Stem cells (Dayt., Ohio) 31, 1563\u20131573 (2013).","journal-title":"Stem cells (Dayt., Ohio)"},{"key":"35481_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7317","volume":"6","author":"H Jahns","year":"2015","unstructured":"Jahns, H. et al. Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs. Nat. Commun. 6, 6317 (2015).","journal-title":"Nat. Commun."},{"key":"35481_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman, J. C. & Verdin, E. Ketone bodies as signaling metabolites. Trends Endocrinol. Metab.: TEM 25, 42\u201352 (2014).","journal-title":"Trends Endocrinol. Metab.: TEM"},{"key":"35481_CR51","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cmet.2013.12.008","volume":"19","author":"VD Longo","year":"2014","unstructured":"Longo, V. D. & Mattson, M. P. Fasting: molecular mechanisms and clinical applications. Cell Metab. 19, 181\u2013192 (2014).","journal-title":"Cell Metab."},{"key":"35481_CR52","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nature09584","volume":"468","author":"S Sengupta","year":"2010","unstructured":"Sengupta, S., Peterson, T. R., Laplante, M., Oh, S. & Sabatini, D. M. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100\u20131104 (2010).","journal-title":"Nature"},{"key":"35481_CR53","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","volume":"17","author":"Y Fang","year":"2013","unstructured":"Fang, Y. et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab. 17, 456\u2013462 (2013).","journal-title":"Cell Metab."},{"key":"35481_CR54","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska, P. & Crawford, P. A. Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 25, 262\u2013284 (2017).","journal-title":"Cell Metab."},{"key":"35481_CR55","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.cmet.2019.09.012","volume":"30","author":"JA Torres","year":"2019","unstructured":"Torres, J. A. et al. Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease. Cell Metab. 30, 1007\u20131023.e1005 (2019).","journal-title":"Cell Metab."},{"key":"35481_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09524-z","volume":"10","author":"N Liang","year":"2019","unstructured":"Liang, N. et al. Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPAR\u03b1. Nat. Commun. 10, 1684 (2019).","journal-title":"Nat. Commun."},{"key":"35481_CR57","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/db10-0958","volume":"60","author":"HC Denroche","year":"2011","unstructured":"Denroche, H. C. et al. Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes 60, 1414\u20131423 (2011).","journal-title":"Diabetes"},{"key":"35481_CR58","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/hep.27907","volume":"62","author":"YS Jo","year":"2015","unstructured":"Jo, Y. S. et al. Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice. Hepatology 62, 1606\u20131618 (2015).","journal-title":"Hepatology"},{"key":"35481_CR59","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.celrep.2016.06.006","volume":"16","author":"B Kucejova","year":"2016","unstructured":"Kucejova, B. et al. Hepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity. Cell Rep. 16, 508\u2013519 (2016).","journal-title":"Cell Rep."},{"key":"35481_CR60","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/hep.25537","volume":"55","author":"K Kim","year":"2012","unstructured":"Kim, K., Pyo, S. & Um, S. H. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver. Hepatology 55, 1727\u20131737 (2012).","journal-title":"Hepatology"},{"key":"35481_CR61","doi-asserted-by":"publisher","first-page":"27950","DOI":"10.1074\/jbc.M100258200","volume":"276","author":"MH Hsu","year":"2001","unstructured":"Hsu, M. H., Savas, U., Griffin, K. J. & Johnson, E. F. Identification of peroxisome proliferator-responsive human genes by elevated expression of the peroxisome proliferator-activated receptor alpha in HepG2 cells. J. Biol. Chem. 276, 27950\u201327958 (2001).","journal-title":"J. Biol. Chem."},{"key":"35481_CR62","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","volume":"15","author":"L Laffel","year":"1999","unstructured":"Laffel, L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes\/Metab. Res. Rev. 15, 412\u2013426 (1999).","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"35481_CR63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman, J. C. & Verdin, E. \u03b2-Hydroxybutyrate: A Signaling Metabolite. Annu. Rev. Nutr. 37, 51\u201376 (2017).","journal-title":"Annu. Rev. Nutr."},{"key":"35481_CR64","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","volume":"139","author":"R Nielsen","year":"2019","unstructured":"Nielsen, R. et al. Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients. Circulation 139, 2129\u20132141 (2019).","journal-title":"Circulation"},{"key":"35481_CR65","doi-asserted-by":"crossref","unstructured":"Wang, Y. H., Liu, C. L., Chiu, W. C., Twu, Y. C. & Liao, Y. J. HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma. Cancers (Basel) 11, 121876 (2019).","DOI":"10.3390\/cancers11121876"},{"key":"35481_CR66","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1172\/JCI76388","volume":"124","author":"DG Cotter","year":"2014","unstructured":"Cotter, D. G. et al. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J. Clin. Investig. 124, 5175\u20135190 (2014).","journal-title":"J. Clin. Investig."},{"key":"35481_CR67","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI6223","volume":"103","author":"S Kersten","year":"1999","unstructured":"Kersten, S. et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Investig. 103, 1489\u20131498 (1999).","journal-title":"J. Clin. Investig."},{"key":"35481_CR68","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/cr.2010.13","volume":"20","author":"YX Wang","year":"2010","unstructured":"Wang, Y. X. PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res. 20, 124\u2013137 (2010).","journal-title":"Cell Res."},{"key":"35481_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08829-3","volume":"10","author":"T Saito","year":"2019","unstructured":"Saito, T. et al. Autophagy regulates lipid metabolism through selective turnover of NCoR1. Nat. Commun. 10, 1567 (2019).","journal-title":"Nat. Commun."},{"key":"35481_CR70","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cell.2011.10.017","volume":"147","author":"H Yamamoto","year":"2011","unstructured":"Yamamoto, H. et al. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell 147, 827\u2013839 (2011).","journal-title":"Cell"},{"key":"35481_CR71","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15\u201320 (2005).","journal-title":"Cell"},{"key":"35481_CR72","first-page":"1013","volume":"16","author":"I Pineda Torra","year":"2002","unstructured":"Pineda Torra, I., Jamshidi, Y., Flavell, D. M., Fruchart, J. C. & Staels, B. Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol. Endocrinol. (Baltim., Md.) 16, 1013\u20131028 (2002).","journal-title":"Mol. Endocrinol. (Baltim., Md.)"},{"key":"35481_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","volume":"14","author":"NL Gluchowski","year":"2017","unstructured":"Gluchowski, N. L., Becuwe, M., Walther, T. C. & Farese, R. V. Jr. Lipid droplets and liver disease: from basic biology to clinical implications. Nat. Rev. Gastroenterol. Hepatol. 14, 343\u2013355 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"35481_CR74","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s42255-021-00342-6","volume":"3","author":"Y Arima","year":"2021","unstructured":"Arima, Y. et al. Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation. Nat. Metab. 3, 196\u2013210 (2021).","journal-title":"Nat. Metab."},{"key":"35481_CR75","doi-asserted-by":"publisher","first-page":"7347","DOI":"10.1073\/pnas.1922344117","volume":"117","author":"PK Luukkonen","year":"2020","unstructured":"Luukkonen, P. K. et al. Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. Proc. Natl Acad. Sci. USA 117, 7347\u20137354 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35481_CR76","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.metabol.2015.12.007","volume":"65","author":"EA Nyenwe","year":"2016","unstructured":"Nyenwe, E. A. & Kitabchi, A. E. The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management. Metab.: Clin. Exp. 65, 507\u2013521 (2016).","journal-title":"Metab.: Clin. Exp."},{"key":"35481_CR77","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24, 908\u2013922 (2018).","journal-title":"Nat. Med."},{"key":"35481_CR78","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1172\/JCI20513","volume":"113","author":"Y Horie","year":"2004","unstructured":"Horie, Y. et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J. Clin. Investig. 113, 1774\u20131783 (2004).","journal-title":"J. Clin. Investig."},{"key":"35481_CR79","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1073\/pnas.0308617100","volume":"101","author":"B Stiles","year":"2004","unstructured":"Stiles, B. et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc. Natl Acad. Sci. USA 101, 2082\u20132087 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35481_CR80","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.2337\/diabetes.52.12.2905","volume":"52","author":"H Ono","year":"2003","unstructured":"Ono, H. et al. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes 52, 2905\u20132913 (2003).","journal-title":"Diabetes"},{"key":"35481_CR81","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jhep.2014.09.012","volume":"62","author":"M Peyrou","year":"2015","unstructured":"Peyrou, M. et al. Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice. J. Hepatol. 62, 421\u2013429 (2015).","journal-title":"J. Hepatol."},{"key":"35481_CR82","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1053\/j.gastro.2013.01.053","volume":"144","author":"HL Kenerson","year":"2013","unstructured":"Kenerson, H. L. et al. Akt and mTORC1 have different roles during liver tumorigenesis in mice. Gastroenterology 144, 1055\u20131065 (2013).","journal-title":"Gastroenterology"},{"key":"35481_CR83","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1073\/pnas.1523693113","volume":"113","author":"SH Ebbesen","year":"2016","unstructured":"Ebbesen, S. H. et al. Pten loss promotes MAPK pathway dependency in HER2\/neu breast carcinomas. Proc. Natl Acad. Sci. USA 113, 3030\u20133035 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"35481_CR84","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/ncb3453","volume":"19","author":"KM Tsanov","year":"2017","unstructured":"Tsanov, K. M. et al. LIN28 phosphorylation by MAPK\/ERK couples signalling to the post-transcriptional control of pluripotency. Nat. cell Biol. 19, 60\u201367 (2017).","journal-title":"Nat. cell Biol."},{"key":"35481_CR85","doi-asserted-by":"publisher","first-page":"3970","DOI":"10.1074\/jbc.C117.775122","volume":"292","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. Extracellular Signal-regulated Kinases (ERKs) Phosphorylate Lin28a Protein to Modulate P19 Cell Proliferation and Differentiation. J. Biol. Chem. 292, 3970\u20133976 (2017).","journal-title":"J. Biol. Chem."},{"key":"35481_CR86","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1172\/JCI95802","volume":"128","author":"SH Jeong","year":"2018","unstructured":"Jeong, S. H. et al. Hippo-mediated suppression of IRS2\/AKT signaling prevents hepatic steatosis and liver cancer. J. Clin. Invest 128, 1010\u20131025 (2018).","journal-title":"J. Clin. Invest"},{"key":"35481_CR87","doi-asserted-by":"publisher","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","volume":"305","author":"JR Clapper","year":"2013","unstructured":"Clapper, J. R. et al. Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. Am. J. Physiol. Gastrointest. Liver Physiol. 305, G483\u2013G495 (2013).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"35481_CR88","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","volume":"25","author":"ML Boland","year":"2019","unstructured":"Boland, M. L. et al. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World J. Gastroenterol. 25, 4904\u20134920 (2019).","journal-title":"World J. Gastroenterol."},{"key":"35481_CR89","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.stem.2013.03.005","volume":"12","author":"N Shyh-Chang","year":"2013","unstructured":"Shyh-Chang, N. & Daley, G. Q. Lin28: primal regulator of growth and metabolism in stem cells. cell stem cell 12, 395\u2013406 (2013).","journal-title":"cell stem cell"},{"key":"35481_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.molcel.2008.09.014","volume":"32","author":"I Heo","year":"2008","unstructured":"Heo, I. et al. Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol. cell 32, 276\u2013284 (2008).","journal-title":"Mol. cell"},{"key":"35481_CR91","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/stem.591","volume":"29","author":"S Peng","year":"2011","unstructured":"Peng, S. et al. Genome-wide studies reveal that Lin28 enhances the translation of genes important for growth and survival of human embryonic stem cells. Stem cells (Dayt., Ohio) 29, 496\u2013504 (2011).","journal-title":"Stem cells (Dayt., Ohio)"},{"key":"35481_CR92","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0092-8674(00)81906-6","volume":"88","author":"EG Moss","year":"1997","unstructured":"Moss, E. G., Lee, R. C. & Ambros, V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 88, 637\u2013646 (1997).","journal-title":"Cell"},{"key":"35481_CR93","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jhep.2010.07.001","volume":"53","author":"J Ji","year":"2010","unstructured":"Ji, J. & Wang, X. W. A Yin-Yang balancing act of the lin28\/let-7 link in tumorigenesis. J. Hepatol. 53, 974\u2013975 (2010).","journal-title":"J. Hepatol."},{"key":"35481_CR94","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrclinonc.2018.28","volume":"15","author":"F Janku","year":"2018","unstructured":"Janku, F., Yap, T. A. & Meric-Bernstam, F. Targeting the PI3K pathway in cancer: are we making headway.?Nat. Rev. Clin. Oncol. 15, 273\u2013291 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"35481_CR95","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu, Y. et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Sci. (N. Y., N. Y.) 332, 1322\u20131326 (2011).","journal-title":"Sci. (N. Y., N. Y.)"},{"key":"35481_CR96","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","volume":"19","author":"J Li","year":"2014","unstructured":"Li, J., Kim, S. G. & Blenis, J. Rapamycin: one drug, many effects. Cell Metab. 19, 373\u2013379 (2014).","journal-title":"Cell Metab."},{"key":"35481_CR97","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41392-021-00497-4","volume":"6","author":"C Xie","year":"2021","unstructured":"Xie, C. et al. Therapeutic potential of C1632 by inhibition of SARS-CoV-2 replication and viral-induced inflammation through upregulating let-7. Signal Transduct. Target. Ther. 6, 84 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"35481_CR98","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR Signaling in Growth, Metabolism, and Disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"35481_CR99","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann, D., Park, S. & Hall, M. N. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat. Rev. Cancer 18, 744\u2013757 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"35481_CR100","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cmet.2012.03.015","volume":"15","author":"A Hagiwara","year":"2012","unstructured":"Hagiwara, A. et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725\u2013738 (2012).","journal-title":"Cell Metab."},{"key":"35481_CR101","doi-asserted-by":"crossref","unstructured":"Fletcher, J. A. et al. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver. JCI insight 5, 127737 (2019).","DOI":"10.1172\/jci.insight.127737"},{"key":"35481_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16991-2","volume":"11","author":"L Barbier-Torres","year":"2020","unstructured":"Barbier-Torres, L. et al. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation. Nat. Commun. 11, 3360 (2020).","journal-title":"Nat. Commun."},{"key":"35481_CR103","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nrgastro.2014.189","volume":"11","author":"G Patman","year":"2014","unstructured":"Patman, G. NAFLD: Ketogenesis could be a determinant of steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 11, 702 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"35481_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19668-y","volume":"11","author":"H Xu","year":"2020","unstructured":"Xu, H. et al. AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis. Nat. Commun. 11, 5807 (2020).","journal-title":"Nat. Commun."},{"key":"35481_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/srep42477","volume":"7","author":"Y Honda","year":"2017","unstructured":"Honda, Y. et al. Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis. Sci. Rep. 7, 42477 (2017).","journal-title":"Sci. Rep."},{"key":"35481_CR106","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","volume":"65","author":"A Montagner","year":"2016","unstructured":"Montagner, A. et al. Liver PPAR\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Gut 65, 1202\u20131214 (2016).","journal-title":"Gut"},{"key":"35481_CR107","doi-asserted-by":"publisher","first-page":"11336","DOI":"10.1074\/jbc.M116.773291","volume":"292","author":"K McDaniel","year":"2017","unstructured":"McDaniel, K. et al. The let-7\/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury. J. Biol. Chem. 292, 11336\u201311347 (2017).","journal-title":"J. Biol. Chem."},{"key":"35481_CR108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmet.2014.05.001","volume":"20","author":"A Umemura","year":"2014","unstructured":"Umemura, A. et al. Liver damage, inflammation, and enhanced tumorigenesis after persistent mTORC1 inhibition. Cell Metab. 20, 133\u2013144 (2014).","journal-title":"Cell Metab."},{"key":"35481_CR109","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","volume":"146","author":"TR Peterson","year":"2011","unstructured":"Peterson, T. R. et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408\u2013420 (2011).","journal-title":"Cell"},{"key":"35481_CR110","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","volume":"32","author":"Y Guri","year":"2017","unstructured":"Guri, Y. et al. mTORC2 Promotes Tumorigenesis via Lipid Synthesis. Cancer Cell 32, 807\u2013823.e812 (2017).","journal-title":"Cancer Cell"},{"key":"35481_CR111","doi-asserted-by":"publisher","first-page":"R1046","DOI":"10.1016\/j.cub.2009.09.058","volume":"19","author":"M Laplante","year":"2009","unstructured":"Laplante, M. & Sabatini, D. M. An emerging role of mTOR in lipid biosynthesis. Curr. Biol.: CB 19, R1046\u2013R1052 (2009).","journal-title":"Curr. Biol.: CB"},{"key":"35481_CR112","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cmet.2013.08.002","volume":"18","author":"DW Lamming","year":"2013","unstructured":"Lamming, D. W. & Sabatini, D. M. A Central role for mTOR in lipid homeostasis. Cell Metab. 18, 465\u2013469 (2013).","journal-title":"Cell Metab."},{"key":"35481_CR113","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cmet.2009.10.004","volume":"10","author":"KF Leavens","year":"2009","unstructured":"Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F. & Birnbaum, M. J. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 10, 405\u2013418 (2009).","journal-title":"Cell Metab."},{"key":"35481_CR114","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23285-8","volume":"12","author":"N Ma","year":"2021","unstructured":"Ma, N. et al. PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling. Nat. Commun. 12, 3059 (2021).","journal-title":"Nat. Commun."},{"key":"35481_CR115","doi-asserted-by":"publisher","first-page":"eabf8271","DOI":"10.1126\/science.abf8271","volume":"376","author":"BS Gosis","year":"2022","unstructured":"Gosis, B. S. et al. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Sci. (N. Y., N. Y.) 376, eabf8271 (2022).","journal-title":"Sci. (N. Y., N. Y.)"},{"key":"35481_CR116","doi-asserted-by":"publisher","first-page":"104500","DOI":"10.1016\/j.phrs.2019.104500","volume":"150","author":"S Feng","year":"2019","unstructured":"Feng, S. et al. Multi-dimensional roles of ketone bodies in cancer biology: Opportunities for cancer therapy. Pharmacol. Res. 150, 104500 (2019).","journal-title":"Pharmacol. Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35481-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35481-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35481-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T01:03:07Z","timestamp":1672016587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35481-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":116,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["35481"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35481-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7940"}}